株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

コンパニオンアニマル向け動物用医薬品:2017年

Animal Pharm Medicines for Companion Animals 2017

発行 Animal Pharm 商品コード 594573
出版日 ページ情報 英文 77 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
コンパニオンアニマル向け動物用医薬品:2017年 Animal Pharm Medicines for Companion Animals 2017
出版日: 2017年12月07日 ページ情報: 英文 77 Pages
概要

当レポートでは、コンパニオンアニマル向け動物用医薬品市場について調査し、現在・将来の市場動向、活発な医薬品企業、コンパニオンアニマル用医薬品の規制、疼痛治療・管理へのアプローチ、および一般的な疾患の治療などについて、詳細に分析しています。

エグゼクティブサマリー

第1章 イントロダクション

  • アニマルヘルス産業
  • コンパニオンアニマル市場
  • サマリー

第2章 コンパニオンアニマルにおいて活発な医薬品企業

  • ZOETIS
  • BOEHRINGER INGELHEIM (+ MERIAL)
  • MERCK/MSD ANIMAL HEALTH
  • ELANCO
  • BAYER ANIMAL HEALTH
  • VIRBAC
  • VETOQUINOL
  • DECHRA PHARMACEUTICALS
  • ARATANA THERAPEUTICS
  • 日本全薬工業

第3章 コンパニオンアニマル医薬品の規制

  • 米国・EUの規制当局
  • 規制ガイダンス
  • コンパニオンアニマル医薬品の可用性
  • 無認可医薬品の使用
  • その他地域の概要

第4章 痛みの治療と管理

  • 疼痛の評価
  • 疼痛治療薬
  • 現在開発中の動物向け製品

第5章 ペットの癌治療

  • 癌治療の評価
  • 現在利用可能な癌治療薬
  • 癌治療薬の将来動向

第6章 アレルギー性皮膚疾患

  • アレルギー性皮膚疾患の評価
  • アレルギー性皮膚疾患治療薬

第7章 心血管疾患

  • 心血管疾患の評価
  • 心臓治療薬
  • 心血管治療薬の将来動向

第8章 抗菌剤:ジレンマ

  • 抗菌剤の利用および抵抗力の発達
  • 抗菌剤の将来動向

第9章 サマリー

目次
Product Code: 87556

This unique report will help companies develop strategies to meet the growing needs of the companion animal sector. The global veterinary drugs market is expected to exhibit a 5.1% compound annual growth rate from 2016-2024. The fastest growth is expected to be in the companion animal sector in economies including the US, BRazil, China and Russia.

The global trend of rising pet ownership increases the demand for pharmaceutical innovations in this sector. This report focuses on two of the world's most popular pets - cats and dogs.

Key insights include:

  • Current and future market trends
  • Active pharmaceutical companies
  • Regulation of companion animal medicine
  • Approaches to pain treatment and management
  • Treatment of common disorders

Table of Contents

Contents

Executive Summary

Introduction

  • 1.1. The Animal Health Industry
  • 1.2. The Companion Animal Sector
    • 1.2.1. Changes in Pet Ownership
    • 1.2.2. The Future of Companion Animal Health in Developed Markets
    • 1.2.3. The Future of Companion Animal Health in Emerging Markets
  • 1.3. Summary

Chapter 2: The Pharmaceutical Companies Active in Companion Animals

  • 2.1. ZOETIS
  • 2.2. BOEHRINGER INGELHEIM (+ MERIAL)
  • 2.3. MERCK/MSD ANIMAL HEALTH
  • 2.4. ELANCO
  • 2.5. BAYER ANIMAL HEALTH
  • 2.6. VIRBAC
  • 2.7. VETOQUINOL
  • 2.8. DECHRA PHARMACEUTICALS
  • 2.9. ARATANA THERAPEUTICS
  • 2.10. NIPPON ZENYAKU KOGYO

Chapter 3: Regulation of Companion Animal Medicines

  • 3.1. The United States (US) and European (EU) Regulatory Authorities
  • 3.2. Regulatory Guidance
  • 3.3. Availability of Companion Animal Medicines
  • 3.4. Use of Unlicensed Medicinal Products
  • 3.5. Overview of Other Regions
    • 3.5.1. BRAZIL
    • 3.5.2. RUSSIA
    • 3.5.3. INDIA
    • 3.5.4. CHINA

Chapter 4: Treatment and Management of Pain

  • 4.1. Evaluating Pain
    • 4.1.1. Future Trends in Assessing Pains
  • 4.2. Pain Therapeutics
    • 4.2.1. Opioids
      • 4.2.1.1. Future Trends for Opiods:
    • 4.2.2. Non-steroidal anti-inflammatory drugs
      • 4.2.2.1. Future trends for NSAIDs
    • 4.2.3. Local anaesthetics
    • 4.2.4. Other analgesics with currently approved veterinary products
    • 4.2.5. Other analgesics without currently approved veterinary products
  • 4.3. Products currently in development for veterinary application

Chapter 5: Treatment of Pet Cancer

  • 5.1. Assessing Cancer Therapies
  • 5.2. Currently Available Cancer Treatments
  • 5.3. Future Trends for Cancer therapy

Chapter 6: Allergic Skin Disorders

  • 6.1. Evaluating Allergic Skin Disease
  • 6.2. Allergic Dermatitis Therapeutics
    • 6.2.1. ACUTE DISEASE FLARES
    • 6.2.2. CHRONIC DISEASE
    • 6.2.3. THE PRODUCTS
    • 6.3. Future trends and products currently in development for the treatment of allergic skin disease.

Chapter 7: Cardiac Disorders

  • 7.1. Assessing Cardiovascular Disease
  • 7.2. Cardiology Therapeutics
    • 7.2.1. Diuretics
    • 7.2.2. Spironolactone
    • 7.2.3. ACE Inhibitors
    • 7.2.4. Pimobendan
    • 7.2.5. Calcium Channel Blockers
    • 7.2.6. Methylxanthines
  • 7.3. Future Trends for Cardiovascular Drugs

Chapter 8: Antimicrobials: A Dilemma

  • 8.1. Antimicrobial use and the Development of Resistance
    • 8.1.1. Antimicrobial prescribing habits and use in companion animal veterinary medicine
  • 8.2. Future trends for antimicrobials

Chapter 9: Summary

References

List of Figures

  • Figure 1: Estimated human equivalent ages for older pets
  • Figure 2: Prevalence of hip dysplasia in a selection of breeds, reproduced from King, 2017.(Data from Orthopedic Foundation for Animals.)
  • Figure 3: Colorado State University canine pain scale
  • Figure 4: An excerpt of the FMPI reproduced from Gruen et al., 2015
  • Figure 5: Voyce Pro dog collar
  • Figure 6: Canine osteosarcoma, reproduced from Biller et al., 2016
  • Figure 7: Image of dog with lymphoma, notice enlarged lymph nodes under jaw
  • Figure 8: Canine Atopic Dermatitis, reproduced from Olivry et al., 2010
  • Figure 9: The CADESI-03 Scale, reproduced from Olivry et al., 2007
  • Figure 10: PVAS, reproduced from Olivry et al., 2007
  • Figure 11: The CADLI, reproduced from Plant et al., 2012
  • Figure 12: Body regions assessed by the SCORFAD Scale, reproduced from Steffan et al., 2012
  • Figure 13: How heart disease affects different body functions
  • Figure 14: Radiographic image of heart enlargement
  • Figure 15: Canine electrocardiography
  • Figure 16: Canine echocardiography

List of Tables

  • Table 1: Number of dogs and cats in the Top 20 pet owning countries
  • Table 2: Companion Animal therapeutic area guidelines issued by the EMA and FDA CVM
  • Table 3: Multifactorial CMIs for chronic pain assessment in veterinary medicine
  • Table 4: Common locations of pet cancers
  • Table 5: Tabs vs mAbs
  • Table 6: Frequency of use of different antimicrobials
  • Table 7: The antibiotics mentioned and frequency with which they were mentioned for the top five indications where antibiotics are said to be prescribed for use in cats
  • Table 8: The antibiotics mentioned and frequency with which they were mentioned for the top five indications where antibiotics are said to be prescribed for use in dogs
Back to Top